S87730 |
JMS-17-2 |
源叶(MedMol) | 98% |
- 产品描述: JMS-17-2 is a potent and selective CX3CR1 antagonist with an IC50 of 0.32 nM. JMS-17-2 impairs metastatic seeding and colonization of breast cancer cells
- 靶点: IC50: 0.32 nM (CX3CR1);CXCR
- 体内研究:
JMS-17-2 (10 mg/kg;腹腔注射;每天两次,持续三周) 导致 SCID 小鼠骨骼和内脏器官的肿瘤显著减少。 Animal Model: SCID mice (~25g) with MDA-231 xenograft Dosage: 10 mg/kg Administration: Aministered i.p.; twice a day for three weeks Result: Caused a dramatic reduction of tumors in both skeleton and visceral organs.
- 参考文献:
1. Shen F, et al. Novel Small-Molecule CX3CR1 Antagonist Impairs Metastatic Seeding and Colonization of Breast Cancer Cells. Mol Cancer Res. 2016 Jun;14(6):518-27.
- 溶解性: Soluble in DMSO
- 保存条件: 2-8℃
- 配置溶液浓度参考:
1mg 5mg 10mg 1 mM 2.381 ml 11.906 ml 23.813 ml 5 mM 0.476 ml 2.381 ml 4.763 ml 10 mM 0.238 ml 1.191 ml 2.381 ml 50 mM 0.048 ml 0.238 ml 0.476 ml
- 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)